Loading... Please wait... Loading... Please wait...
ESTIMATED
05/01/2024
05/01/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.45 | $0.45 | $0.45 |
| Q2 2024 | 8 | $0.49 | $0.49 | $0.49 |
| Q3 2024 | 3 | $0.44 | $0.44 | $0.44 |
| Q4 2024 | 5 | $0.47 | $0.47 | $0.47 |
| Q1 2025 | 4 | $0.54 | $0.54 | $0.54 |
| Q2 2025 | 6 | $0.56 | $0.56 | $0.56 |
| Q3 2025 | 4 | $0.52 | $0.52 | $0.52 |
| Q4 2025 | 6 | $0.53 | $0.53 | $0.53 |
| Q1 2026 | 3 | $0.61 | $0.61 | $0.61 |
| Q2 2026 | 5 | $0.63 | $0.63 | $0.63 |
Bio-Techne Corporation last posted its earnings results on Wednesday, May 1st, 2024. The company reported $0.48 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The company had revenue of 303.43 M for the quarter and had revenue of 1.14 B for the year. Bio-Techne Corporation has generated $2 earnings per share over the last year ($1.76 diluted earnings per share) and currently has a price-to-earnings ratio of 55.36. Bio-Techne Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/06/2024 | Q3 2024 | $0.31 | $292.15 M | $303.43 M | 02/07/2024 | Q2 2024 | $0.17 | $277.55 M | $272.60 M | 11/07/2023 | Q1 2024 | $0.32 | $276.94 M | 08/23/2023 | Q4 2023 | $0.48 | $301.32 M | 05/08/2023 | Q3 2023 | $0.45 | $296.61 M | $294.15 M | 02/07/2023 | Q2 2023 | $0.32 | $288.80 M | $271.58 M | 11/07/2022 | Q1 2023 | $0.57 | $269.66 M | 08/24/2022 | Q4 2022 | $0.39 | $288.23 M | 05/09/2022 | Q3 2022 | $0.39 | $290.38 M | 02/07/2022 | Q2 2022 | $0.51 | $266.44 M | $269.28 M | 11/08/2021 | Q1 2022 | $0.45 | $252.78 M | $257.72 M | 08/25/2021 | Q4 2021 | $0.10 | $244.65 M | $259.03 M | 05/07/2021 | Q3 2021 | $0.29 | $243.55 M | 02/08/2021 | Q2 2021 | $0.30 | $206.50 M | $224.25 M | 11/09/2020 | Q1 2021 | $0.22 | $185.03 M | $204.20 M | 08/26/2020 | Q4 2020 | $0.38 | $163.91 M | $175.83 M | 05/11/2020 | Q3 2020 | $0.24 | $194.68 M | 02/06/2020 | Q2 2020 | $0.78 | $191.24 M | $184.93 M | 11/06/2019 | Q1 2020 | $0.09 | $179.40 M | $183.24 M | 08/28/2019 | Q4 2019 | $0.11 | $197.76 M | $191.66 M |
|---|
A. Bio-Techne Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates.
A. In the previous quarter, Bio-Techne Corporation (NASDAQ:TECH) reported $0.48 earnings per share (EPS) to beat the analysts' consensus estimate of $0.46 by $0.02.
A. The conference call for Bio-Techne Corporation's latest earnings report can be listened to online.
A. The conference call transcript for Bio-Techne Corporation's latest earnings report can be read online.
A. Bio-Techne Corporation (NASDAQ:TECH) has a recorded annual revenue of $1.14 B.
A. Bio-Techne Corporation (NASDAQ:TECH) has a recorded net income of $1.14 B. Bio-Techne Corporation has generated $1.81 earnings per share over the last four quarters.
A. Bio-Techne Corporation (NASDAQ:TECH) has a price-to-earnings ratio of 55.36 and price/earnings-to-growth ratio is 4.34.
